45. Capstick, T. G. et al.: Expert Rev Respir Med 6(1), 91-103 (2012).
Benke, E., Farkas, Á., Balásházy, I., Szabó-Révész, P., Ambrus, R.:The actuality of devices for the delivery of dry powder inhalation, formulations and modern assemblies I.
The aim of the pulmonary drug delivery may be a local and systemic treatment. The most of inhalation products are for local therapy on the market. Product developers should consider preparations for this purpose that lung lesions affect the deposition of the drug. However, products for systemic treatment are already available and more and more publications are about the growth of the significance of the latter. Upgrading Dry Powder Inhaler (DPI) devices will help optimize delivery of inhaled products. This is why we are talking about a constantly evolving sector. This publication provides a comprehensive view of a wide range of these devices, focusing on models that are on the market in Hungary. Furthermore, it describes the historical background, requirements and systematization of DPI devices. As the introduction also revealed, there are a number of requirements that companies need to take into account when upgrading their tools. Most importantly, from the point of view of patient compliance, despite these improvements, these devices are as simple as possible for patients.
Ludasi, K., Oláh, I., Regdon jr., G.*: Protection against the counterfeiting of medicines, the application of modern identification technologies on drugs Part II.
The presence of counterfeit and substandard medicines increases year by year. These drugs pose a great threat as they either lack the expected effect or cause direct health damage, even death, and undermine confidence in the health organizations; furthermore, they also cause serious social and economic damage. The problem can no longer be ignored.
Purpose:To survey the fake drug consumption in Hungary and abroad, learn about the latest anti-conterfeit policies and legislation, describe the definition of the fake drugs, study the consequences of using a fake drug for the individuals or for the society, find Counterfeiting Strategies, clarify the authentication principle, find and present the latest anti-counterfeiting technologies.
Methods:Thesystematic review of articles on the websites of counterfeit and substandard medicines, plus through Web of Science, Google Scholar and ScienceDirect.com using the keywords „counterfeit medicine”, „counterfeit drug”, „falsified medicine”, „falsified drug”, ”fake medicine”, „fake drug.” Furthermore, European Medicines Agency, World Health Organization, U.S. Food & Drug Administration, Interpol websites were overviewed for more information.
Results: According to statistics, the proportion of counterfeit drugs on the market is growing. In recent years, good governance measures have been put in place to curb counterfeiting, a European Medicrime Convention has been set up, the penal code has been amended and international co-operation strengthened. In Africa and some parts of Asia still 30% of the drugs sold are false. Nigeria, on the other hand, is a good example that proper state control and inspection can decrease counterfeiting. The amount of counterfeit medicines sold on the Internet is 50% and it is growing.
Conclusions:Communication between governments and agencies has begun, a directive on counterfeiting has been launched in Europe, which seem to stop the expansion of counterfeit medicines in Europe’s legal networks. The patient should be aware of the fact that he is able to assess the risk of using drugs of unknown origin. It is necessary to teach the people how to verify the authenticity of the website when shopping online. There is an urgent need for effective and concrete international mobilization against these criminal organizations, mostly in Asia and in Africa. It is a great success that some of these countries have efficiently joined the anti-counterfeiting action this year.
Key-words: counterfeiting of medicines, identification, anti-counterfeiting
3. American College of Clinical Pharmacy. Qualifications of pharmacists who provide direct patient care: perspectives on the need for residency training and board certification. In.: Pharmacotherapy 33(8), 888-91 (2013).
4. Az ISO 9001 alkalmazása egészségügyi szolgáltató szervezetek számára. Ajánlás. ESZCSM, 2003.
5. A klinikai hatékonyság fejlesztése az egészségügyben, szerk. Gődény Sándor és tsi. ProDie, 2007.
10. ISO 9000 szabványcsalád, azon belül is EN ISO 9001:2015 Minőségirányítási rendszerek. Követelmények nemzetközi szabvány
Becskeházi-Tar A.: Quality assurance and quality management in clinical pharmacy Part. I.
Quality management of hospital pharmacy is a complex task and it is difficult to demonstrate the good and the best practices. The purpose of the communication is to raise awareness about the subject, present problems and challenges to meet the future.
21. Johns, R., Roberts, C.M.: Prescriber18(3), 16-28 (2007).
Doró, P.: Therapy of asthma, pharmaceutical aspects
The article gives an overview on asthma, including the symptoms, provoking factors and diagnosis. It explains the fundamentals of the pharmacotherapy of asthma. As mainly inhaled medications are used in asthma, the article provides detailed information on the proper use of different inhalation devices. Finally, the role of the pharmacist in asthma care is discussed.
Pflanzendüfte. Ecomed. Verlagsges. AG und Co., KG, Landsberg, 1997.
9. Schmidt G., Tóth I.: Kertészeti dendrológia. Mezőgazda Kiadó, Budapest, 2006.
10. Józsa M., Kósa G.: Magyar Mezőgazdaság online, 2011. 07. 06.
Szabó, L. Gy.: Lime tree of King Matthias
2018 is the year of Matthias Corvinus in Hungary. Matthias Corvinus was King of Hungary from 1458 to 1490 until his death. He had a pioneering role in the establishment of the Hungarian Renaissance Royal Gardens. Even today, there are very old lime trees bearing the name of King Matthias.